BioTrillion heart pulsing animation

The current global health pandemic has accelerated the urgency of detecting diease signs – before becoming symptomatic.  This has never been more important – for all diseases.

BioTrillion is a little startup with bold ambitions to accessibly and scalably advance healthcare – via Digital Biomarkers.

Data from Life.
Data for Life.™

Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health.  There is a better way.

Every human generates massive amounts of life data that will unlock novel health insights & interventions.

The cycle of getting data from life and getting data for life

We are developing a mobile health technology platform called BioEngine4D™ – to digitally detect drugs & diseases – by measuring data from life, analyzing it through computational advancements in machine vision and artificial intelligence, and applying it back for life.

Neurologic Impairment

Machine Eyes meet Human Eyes meet A.I.

What if...1 billion global human lives could be enabled with access to radically novel health insights – using only their smartphone?  The solution is looking at you everyday.

Neural Nets for Neural Health

Our journey begins in Neurology.  The first set of digital biomarkers we are developing (and have developed) offer more scalable and actionable applications in Neurology for:

BioTrillion, Inc. was incorporated in December 2017 with our headquarters in San Francisco, CA.  We are reimagining Life Sciences through the fundamental principles of many sciences.

Our mission is to enable Consumer technology to empower ordinary Consumers with extraordinary health abilities.  Advances in technology have amplified our individual capabilities in many domains, and healthcare should be no exception.



The world so often thinks of Healthcare as an industry, that it tends to forget about Healthcare as a purpose.

BioTrillion aims to optimize quality of life and longevity by reframing our approach to health solutions from the Consumer's perspective across 3 key temporal phases: the “Prevention,” “Detection,” and “Intervention” of diseases.

Sequential timeline of preventing, detecting, and intervening of health disorders
1% spent in medical setting

We spend less than 1% of our time in a Medical setting and hope the medical data generated there will lead to enhanced outcomes.  Medical data is abundant, but its format is siloed, unstructured, and intermittent.  As a result, a massive amount of Medical data is not being adequately connected to our healthcare.  Medical settings offer access to tremendous medical experience and clinically-validated diagnostics; however, their utility will always be fundamentally limited given the typical Consumer only spends < 1% of their total time in an actual Medical setting.

99% of time spend outside of medical setting

The Life setting provides access to something the Medical setting does not — that other 99% of time.  It is during this massive gap in time where the signs of developing diseases may be expressed, but go undetected, yielding both clinical and economic opportunities for much more effective (frequent, objective, quantitative) and scalable (accessible, affordable, convenient) consumer health solutions.  We believe health solutions of the future will come from within the Life setting, via LIFEdata™ (sensor-measured information generated from and around life) and its computationally analytic conversion to digital biomarkers.

More about Healthcare


Today, life information is exponentially transitioning out of an analog world and into a digital one.  An increasing number of sensors in our smart devices are entering our Life setting and have the ability to capture many earlier signs of disease in the form of LIFEdata through multiple modalities.  These sensors are often disparate and thus limited in perspective when analyzed alone, yet are synergistic in value when analyzed interconnectedly.

Capture developing diseases using everyday technology

BioTrillion is focused on generating LIFEdata from these sensors along with aggregating labelled Medical data, and training BioEngine4D through machine learning and artificial intelligence to statistically and digitally measure disease development and disease response to drugs.

Transfer Lifedata to BioEngine4D and into Medical Data

BioEngine4D is being developed as a more effective and scalable health technology solution — for Consumers.  We aim to augment Consumers' own self-healthcare abilities, helping to bridge the gap between the Medical and Life settings.  Afterall, no one will care more for your health than you.

Novel technologies that have been synergistically applied to traditional domains have yielded entirely new opportunities to solve old problems in new ways.  We see an inflection point in the future where the health value of data generated in the Life setting will exceed that of data generated in the Medical setting.  And where innovative solutions to measuring potential diseases will be oriented around frequency, dimensionality, quantification (for the computer) and accessibility, affordability, convenience (for the consumer) - yielding better efficacy and efficiency for all.  Solutions that — in retrospect — will make us realize that our health has been "in the dark" 99% of the time.

We believe that Data from Life should be Data for Life.


More about BioEngine4D

NVIDIA Features BioTrillion @ GTC Startup Showcase

Animated Explainer


Nvidia Inception Program Badge

COVID-19 has greatly impacted the world.  We wish our fellow startups that survive will emerge even stronger.  Despite being a small startup ourselves, BioTrillion is contributing ~25% of our time during this pandemic toward synergistically extending our capabilities at the intersection of physiology and technology, yielding 3 scalable mitigation solutions for COVID-19 – and inevitable future pandemics – garnering interest from the public and private sectors.

Enroll Here to be Added to Release Updates

© 2020 BioTrillion, Inc. | All Rights Reserved Worldwide | Terms of Use